National

The daily dose: September 27, 2021

Jyothi Datta PT Mumbai | Updated on September 27, 2021

We curate some of the top stories of Covid-19 for you

# Vaccinations @86: India has administered over 86 crore total doses of the Covid-19 vaccine. Uttar Pradesh tops the list in terms of the highest number of first doses administered, followed by Maharashtra and Madhya Pradesh.

https://www.thehindubusinessline.com/news/national/covid-19-vaccination-india-administers-over-86-crore-doses/article36689492.ece

# More than just Covaxin: The story behind the vaccine development and dose of innovation the Ellas have brought to India’s biotech industry.

https://www.thehindubusinessline.com/specials/corporate-file/bharat-biotech-more-than-just-covaxin/article36684598.ece?homepage=true

# Licence to travel: The recent Indo-UK imbroglio has illustrated the inadequacy of a system that views a vaccine certificate or passport as an additional “licence to travel”, something that public health experts have been calling out for sometime now.

https://www.thehindubusinessline.com/news/vaccine-passports-and-certificates-should-not-become-licence-to-travel-say-experts/article36682177.ece

#Vaccination primes economy?: India’s economy showed signs it’s ready to accelerate, thanks to its services sector resuming expansion and manufacturing activity retaining growth momentum in August, says a report.

The monthly expansion in services and manufacturing activity coincided with relatively low new Covid-19 cases and a pick-up in the pace of vaccinations — more than 834 million doses have been administered so far in the nation of 1.3 billion people. That said, less than a fifth of the population is fully vaccinated and risks of a third wave of infections persist.

https://www.thehindubusinessline.com/economy/brisk-covid-vaccination-rate-primes-indian-economy-for-acceleration/article36689426.ece

Published on September 27, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like